46 related articles for article (PubMed ID: 22006369)
1. Endoscopic resection for synchronous esophageal squamous cell carcinoma and gastric adenocarcinoma in early stage is a possible alternative to surgery.
Park SJ; Ahn JY; Jung HY; Na S; Park SE; Kim MY; Choi KS; Lee JH; Kim DH; Choi KD; Song HJ; Lee GH; Kim JH; Han S
Gut Liver; 2015 Jan; 9(1):59-65. PubMed ID: 25170061
[TBL] [Abstract][Full Text] [Related]
2. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Morgan E; Soerjomataram I; Gavin AT; Rutherford MJ; Gatenby P; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Jackson C; Kozie S; Little A; Møller B; Shack L; Tervonen H; Thursfield V; Vernon S; Walsh PM; Woods RR; Finley C; Merrett N; O'Connell DL; Reynolds JV; Bray F; Arnold M
Gut; 2021 Feb; 70(2):234-242. PubMed ID: 32554620
[TBL] [Abstract][Full Text] [Related]
3. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.
Morgan E; Soerjomataram I; Rumgay H; Coleman HG; Thrift AP; Vignat J; Laversanne M; Ferlay J; Arnold M
Gastroenterology; 2022 Sep; 163(3):649-658.e2. PubMed ID: 35671803
[TBL] [Abstract][Full Text] [Related]
4. The management of a patient with an operable carcinoma of the oesophagus.
Crosby T; Evans M; Gillies RS; Maynard ND
Ann R Coll Surg Engl; 2009 Jul; 91(5):366-70. PubMed ID: 19622256
[No Abstract] [Full Text] [Related]
5. Treatment of esophagogastric junction carcinoma: an unsolved debate.
Orditura M; Galizia G; Lieto E; De Vita F; Ciardiello F
World J Gastroenterol; 2015 Apr; 21(15):4427-31. PubMed ID: 25914451
[TBL] [Abstract][Full Text] [Related]
6. Clinical-pathological characteristics and prognosis of a cohort of oesophageal cancer patients: a competing risks survival analysis.
Rodríguez-Camacho E; Pita-Fernández S; Pértega-Díaz S; López-Calviño B; Seoane-Pillado T
J Epidemiol; 2015; 25(3):231-8. PubMed ID: 25716135
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the surgical treatment strategies for Siewert type II squamous cell carcinoma in the same area as esophagogastric junction carcinoma: data from a single Japanese high-volume cancer center.
Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
Surg Today; 2014 Aug; 44(8):1522-8. PubMed ID: 24166133
[TBL] [Abstract][Full Text] [Related]
9. Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma.
Murphy CC; Correa AM; Ajani JA; Komaki RU; Welsh JW; Swisher SG; Hofstetter WL
J Gastrointest Surg; 2013 Aug; 17(8):1359-69. PubMed ID: 23715646
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in esophageal cancer outcomes.
Revels SL; Morris AM; Reddy RM; Akateh C; Wong SL
Ann Surg Oncol; 2013 Apr; 20(4):1136-41. PubMed ID: 23263780
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in surgical resection and survival among elderly patients with poor prognosis cancer.
Revels SL; Banerjee M; Yin H; Sonnenday CJ; Birkmeyer JD
J Am Coll Surg; 2013 Feb; 216(2):312-9. PubMed ID: 23195204
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor expression and neoadjuvant therapy in esophageal adenocarcinoma.
Trowbridge R; Sharma P; Hunter WJ; Agrawal DK
Exp Mol Pathol; 2012 Aug; 93(1):147-53. PubMed ID: 22546272
[TBL] [Abstract][Full Text] [Related]
13. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry.
Beg MS; Navaneethan U; Atiq M; Komrokji R; Safa M
Am J Clin Oncol; 2009 Jun; 32(3):286-90. PubMed ID: 19433959
[TBL] [Abstract][Full Text] [Related]
14. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus.
Bass GA; Furlong H; O'Sullivan KE; Hennessy TP; Walsh TN
Eur J Cancer; 2014 Apr; 50(6):1065-75. PubMed ID: 24480403
[TBL] [Abstract][Full Text] [Related]
16. Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer.
Bollschweiler E; Hölscher AH; Metzger R
Future Oncol; 2010 Jan; 6(1):25-35. PubMed ID: 20021207
[TBL] [Abstract][Full Text] [Related]
17. Multimodal therapy of GEJ cancer: when is the definitive radiochemotherapy the treatment of choice?
Stahl M
Recent Results Cancer Res; 2012; 196():181-5. PubMed ID: 23129374
[TBL] [Abstract][Full Text] [Related]
18. Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States.
Merkow RP; Bilimoria KY; McCarter MD; Chow WB; Gordon HS; Stewart AK; Ko CY; Bentrem DJ
Cancer; 2012 Jul; 118(13):3268-76. PubMed ID: 22006369
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
